Kansas City Blood and Marrow Transplant Program

The Kansas City Blood and Marrow Transplant Program (KCBMT) is a specialized healthcare provider and clinical research center located in Kansas City, Missouri. Operating as a joint initiative between Sarah Cannon Cancer Institute and Research Medical Center, the program provides comprehensive care for patients with blood cancers and other complex hematologic disorders. KCBMT offers advanced therapeutic options, including autologous and allogeneic stem cell transplants, as well as FDA-approved cellular therapies like CAR-T cell therapy. As a FACT-accredited facility, the program is a leader in the region for clinical trials, offering patients access to innovative treatments for leukemia, lymphoma, and multiple myeloma. The multidisciplinary team at KCBMT focuses on delivering personalized, high-quality care through the entire continuum of transplant and cellular therapy services.